Summary of Purpose
RESTART- fr is a randomised controlled trial for adults surviving spontaneous intracerebral haemorrhage who had taken an antithrombotic drug (i.e. anticoagulant or antiplatelet medication) for the prevention of vaso-occlusive disease before the ICH. RESTART- fr is testing whether a policy of starting antiplatelet drugs (one or more of aspirin, clopidogrel, or dipyridamole, chosen at investigator's discretion)...Read More →
The following dates are available for this trial. Trial information last updated on 18 May 2017.
|7 Dec 2016||13 Jul 2016||1 Nov 2018||1 Nov 2019||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Hilde HENON, MD, PhD